MY ACCOUNT | NEWSLETTER |

Genomic Medicine in Canine Periodontal Disease: A Systematic Review


Periodontal disease is one of many conditions that affect the oral cavity of companion animals and humans. Through animal models, namely the dog, it has been possible to increase our knowledge about this disease. Currently, one of the most explored areas is genomic medicine. Through it, it will be possible to implement individualized and early strategies to prevent the development of periodontal disease. In light of the limited existing information, the aim of the present study was to systematically review the existing scientific literature regarding genomic medicine in canine periodontal disease, focusing on the genes already studied and their probable potential.

Six articles were selected and analyzed in detail. Only in two of them was it possible to determine that the studied genetic variations could be potential biomarkers to determine the susceptibility to the development of periodontal disease. This fact reinforces the need for further studies in this field, since it is clear that the future of human and veterinary medicine will involve an approach based on the genetic characteristics of each individual.

Genomic medicine has become a growing reality; however, it is still taking its first steps in veterinary medicine. Through this approach, it will be possible to trace the genetic profile of a given individual and thus know their susceptibility to certain diseases, namely periodontal disease. This condition is one of the most frequently diagnosed in companion animal clinics, especially in dogs. Due to the limited existing information and the lack of comprehensive studies, the objective of the present study was to systematically review the existing scientific literature regarding genomic medicine in canine periodontal disease and determine which genes have already been studied and their probable potential. This study followed the recommendations of the PRISMA 2020 methodology. Canine periodontal disease allied to genomic medicine were the subjects of this systematic review.

Only six articles met all of the inclusion criteria, and these were analyzed in detail. These studies described genetic variations in the following genes: interleukin-6, interleukin-10, interleukin-1, lactotransferrin, toll-like receptor 9, and receptor activator of nuclear factor-kappa B. Only in two of them, namely interleukin-1 and toll-like receptor 9 genes, may the identified genetic variations explain the susceptibility that certain individuals have to the development of periodontal disease. It is necessary to expand the studies on the existing polymorphic variations in genes and their relationship with the development of periodontal disease.

Only then will it be possible to fully understand the biological mechanisms that are involved in this disease and that determine the susceptibility to its development.


Read the full article here.


Authors: Carolina Silva, João Requicha, Isabel Dias, Estela Bastos, Carlos Viegas

Source: https://www.mdpi.com/

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

“The Street Vet” Dr. Kwane Stewart Visits Campus

Like0
Dislike0

Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference

Like0
Dislike0

Successful management of feline pemphigus foliaceus with pentoxifylline and topical hydrocortisone aceponate

Like0
Dislike0

Current and Future Molecular Diagnostics of Tick-Borne Diseases in Cattle

Like0
Dislike0

Subclinical bacteriuria and pyuria in companion animals without signs of lower urinary tract disease: prevalence and associations in a prospective cross-sectional study using multimodal analytics.

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top